abstract |
The present invention relates to a combination product containing a limonoid (and pharmaceutically acceptable derivatives, esters, stereoisomers, salts or prodrugs thereof) and dipeptidyl peptidase-4 (DPP-4) inhibitors (such as sitagliptin, saxagliptin, vildagliptin, linagliptin, alogliptin, trelagliptin and omarigliptin). The present invention also relates to use of the combination product in the treatment and/or prevention of diseases associated with diabetes and so on. |